Mark Schoenebaum - Net Worth and Insider Trading

Mark Schoenebaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Schoenebaum owns 3 companies in total, including Immunovant Inc (IMVTU) , TG Therapeutics Inc (TGTX) , and Immunovant Inc (IMVT) .

Click here to see the complete history of Mark Schoenebaum’s form 4 insider trades.

Insider Ownership Summary of Mark Schoenebaum

Ticker Comapny Transaction Date Type of Owner
IMVTU Immunovant Inc 2019-05-09 director
TGTX TG Therapeutics Inc 2012-04-16 director
IMVT Immunovant Inc 2019-05-09 director

Mark Schoenebaum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Schoenebaum Ownership Network

Ownership Network List of Mark Schoenebaum

No Data

Ownership Network Relation of Mark Schoenebaum


Mark Schoenebaum Owned Company Details

What does Immunovant Inc do?

Who are the key executives at Immunovant Inc?

Mark Schoenebaum is the director of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and Chief Scientific Officer Michael James Elliott .

Immunovant Inc (IMVTU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunovant Inc Insider Transactions

No Available Data

Mark Schoenebaum Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Schoenebaum. You might contact Mark Schoenebaum via mailing address: 787 Seventh Avenue, 48th Floor, New York Ny 10019.

Discussions on Mark Schoenebaum

No discussions yet.